Tangye SG, Nguyen T, Deenick EK, Bryant VL, Ma CS. Inborn errors of human B cell development, differentiation, and function. J Exp Med. 2023;220(7):e20221105. https://doi.org/10.1084/jem.20221105.
Article CAS PubMed PubMed Central Google Scholar
Melchers F. Checkpoints that control B cell development. J Clin Invest. 2015;125(6):2203–10. https://doi.org/10.1172/JCI78083.
Article PubMed PubMed Central Google Scholar
Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131(4):959–71. https://doi.org/10.1016/j.jaci.2013.01.046.
Article CAS PubMed Google Scholar
Morgan D, Tergaonkar V. Unraveling B cell trajectories at single cell resolution. Trends Immunol. 2022;43(3):210–29. https://doi.org/10.1016/j.it.2022.01.003.
Article CAS PubMed Google Scholar
Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473–507. https://doi.org/10.1007/s10875-022-01289-3.
Article PubMed PubMed Central Google Scholar
Ferrari S, Lougaris V, Caraffi S, Zuntini R, Yang J, Soresina A, Meini A, Cazzola G, Rossi C, Reth M, Plebani A. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med. 2007;204(9):2047–51. https://doi.org/10.1084/jem.20070264.
Article CAS PubMed PubMed Central Google Scholar
Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang YD, Coustan-Smith E, Smith AM, Perez EE, Murray PJ. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J Exp Med. 2012;209(3):463–70. https://doi.org/10.1084/jem.20112533.
Article CAS PubMed PubMed Central Google Scholar
Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, Coustan-Smith E, Howard V, Campana D. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227. https://doi.org/10.1146/annurev.immunol.021908.132649.
Article CAS PubMed Google Scholar
Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest. 1999;104(8):1115–21. https://doi.org/10.1172/JCI7696.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Kanegane H, Sanal O, Tezcan I, Ersoy F, Futatani T, Miyawaki T. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet. 2002;108(4):333–6. https://doi.org/10.1002/ajmg.10296.
Khalili A, Plebani A, Vitali M, Abolhassani H, Lougaris V, Mirminachi B, Rezaei N, Aghamohammadi A. Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a. J Clin Immunol. 2014;34(2):138–41. https://doi.org/10.1007/s10875-014-9989-3.
Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, van der Flier M. IgM Augments Complement bactericidal activity with serum from a patient with a novel CD79a mutation. J Clin Immunol. 2018;38(2):185–92. https://doi.org/10.1007/s10875-017-0474-7.
Article CAS PubMed PubMed Central Google Scholar
Ben-Ali M, Kechout N, Mekki N, Yang J, Chan KW, Barakat A, Aadam Z, Gamara J, Gargouri L, Largueche B, BelHadj-Hmida N, Nedri A, Ameur HB, Mellouli F, Boukari R, Bejaoui M, Bousfiha A, Ben-Mustapha I, Lau YL, Barbouche MR. Genetic approaches for definitive diagnosis of agammaglobulinemia in consanguineous families. J Clin Immunol. 2020;40(1):96–104. https://doi.org/10.1007/s10875-019-00706-4.
Article CAS PubMed Google Scholar
Wang Y, Chen X, Yang Q, Tang W, Jia Y, Zhou L, An Y, Zhang Z, Tang X, Zhao X. E1021K homozygous mutation in PIK3CD leads to activated PI3K-Delta Syndrome 1. J Clin Immunol. 2020;40(2):378–87. https://doi.org/10.1007/s10875-020-00749-y.
Article CAS PubMed Google Scholar
Li W, Sun Y, Yu L, Chen R, Gan R, Qiu L, Sun G, Chen J, Zhou L, Ding Y, Du H, Shu Z, Zhang Z, Tang X, Chen Y, Zhao X, Zhao Q, An Y. Multiple immune defects in two patients with novel DOCK2 mutations result in recurrent multiple infection including live attenuated virus vaccine. J Clin Immunol. 2023;43(6):1193–207. https://doi.org/10.1007/s10875-023-01466-y.
Article CAS PubMed Google Scholar
Yu L, Li W, Lv G, Sun G, Yang L, Chen J, Zhou L, Ding Y, Zhang Z, Tang X, An Y, Zhao X. De novo somatic mosaicism of CYBB caused by intronic LINE-1 element insertion resulting in chronic granulomatous disease. J Clin Immunol. 2023;43(1):88–100. https://doi.org/10.1007/s10875-022-01347-w.
Article CAS PubMed Google Scholar
Tang W, Zhang Y, Luo C, Zhou L, Zhang Z, Tang X, Zhao X, An Y. Clinical application of metagenomic next-generation sequencing for suspected infections in patients with primary immunodeficiency disease. Front Immunol. 2021;13(12):696403. https://doi.org/10.3389/fimmu.2021.696403.
Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–60. https://doi.org/10.1146/annurev.iy.11.040193.001555.
Article CAS PubMed Google Scholar
Gofshteyn J, Cárdenas AM, Bearden D. Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-Linked Agammaglobulinemia. Pediatr Neurol. 2016;64:94–8. https://doi.org/10.1016/j.pediatrneurol.2016.06.014.
Vermeersch G, Laenen L, Lens G, van der Elst KCM, Thal DR, Jentjens S, Demaerel P, Van Nieuwenhuyse T, Wollants E, Boeckx N, Verhaert N, Dubois B, Kuppeveld FJM, Woei-A-Jin FJSH. Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis. Eur J Neurol. 2022;29(10):3117–23. https://doi.org/10.1111/ene.15478.
Jones TPW, Buckland M, Breuer J, Lowe DM. Viral infection in primary antibody deficiency syndromes. Rev Med Virol. 2019;29(4):e2049. https://doi.org/10.1002/rmv.2049.
Article CAS PubMed Google Scholar
Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-Linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract. 2016;4(6):1059–65. https://doi.org/10.1016/j.jaip.2015.12.015.
Bauer L, Manganaro R, Zonsics B, Strating JRPM, El Kazzi P, Lorenzo Lopez M, Ulferts R, van Hoey C, Maté MJ, Langer T, Coutard B, Brancale A, van Kuppeveld FJM. Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner. ACS Infect Dis. 2019;5(9):1609–23. https://doi.org/10.1021/acsinfecdis.9b00179.
Article CAS PubMed PubMed Central Google Scholar
Hurdiss DL, El Kazzi P, Bauer L, Papageorgiou N, Ferron FP, Donselaar T, van Vliet ALW, Shamorkina TM, Snijder J, Canard B, Decroly E, Brancale A, Zeev-Ben-Mordehai T, Förster F, van Kuppeveld FJM, Coutard B (2022) Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex. Sci Adv 8(1):eabj7615. https://doi.org/10.1126/sciadv.abj7615
Tyler KL. Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis. JAMA Neurol. 2015;72(5):493–4. https://doi.org/10.1001/jamaneurol.2014.4625.
Article PubMed PubMed Central Google Scholar
Chawla S, Jindal AK, Arora K, Tyagi R, Dhaliwal M, Rawat A. T Cell Abnormalities in X-Linked agammaglobulinaemia: an updated review. Clin Rev Allergy Immunol. 2023;65(1):31–42. https://doi.org/10.1007/s12016-022-08949-7.
Article CAS PubMed Google Scholar
Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, Yel L, Sullivan KE. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–32. https://doi.org/10.1007/s10875-014-0056-x.
留言 (0)